An advocate of change, specifically change within our energy system and landscape which creates a more sustainable and equitable tomorrow.
Andrew strongly believes in the need to infuse data and digitalisation with systems and infrastructure to enable a sustainable global transition to a low carbon economy.
Working for over 20 years within the engineering sector, Andrew has held programme and account management positions throughout his career and more recently lead a data services practice for Siemens throughout EMEA before joining SI-B and leading the Sustainability division within GB&I.
Passionate about decarbonisation and the sustainable transformation of the energy system. More than 25 years of international experience as manager, advisor, business developer, strategist, project manager and trainer in energy efficiency, sustainability, and international development cooperation. Background in energy engineering with a PhD on energy efficiency from the University of Aachen. Authored and co-authored several publications and books on energy efficiency in the industrial sector and on climate change policy topics.
Harminder specializes in research in the Power, Renewable Energy and Smart Grid sectors. He has more than 20 years of experience, most of which has been in energy sector research.
At GlobalData, Harminder manages research and analysis in the Power sector and is responsible for the company’s Power Intelligence Center.
He has led a large number of studies in the power and renewable energy sectors covering various aspects, including generation, transmission, distribution, smart grids, equipment, power trading, tariffs, policy and regulatory aspects, etc.
Thomas Seeber is the Director – Data Center Power Generation. He holds an Electrical Engineering degree, a Bachelor’s in Management & Economics, and a Master’s in International Business. In his previous roles, Thomas served as the Global Warranty Leader for Jenbacher gas engines, Service Product Manager for GE Distributed Power’s Type 6 gas engine platform before he decided 7 years ago to join the global sales organization of INNIO Jenbacher, where he currently is Director of Global Technical Sales.
Markus Strömich-Jenewein, Director of Commercial Strategy & Business Development at INNIO Group is responsible for developing and implementing the commercial strategy for the Jenbacher brand, including the Jenbacher H2-Engine platforms. As a seasoned sales professional, he focuses on identifying and capitalizing on opportunities in the global energy landscape, particularly in decentralized hydrogen-based energy solutions. Markus also serves on INNIO Group’s Sustainability Board and has been with the organization since 2007. He holds a master’s degree in international management from the University of Applied Sciences in Graz, Austria.
Nourhène Esseghir is a Development Projects Manager at Unither Pharmaceuticals, leading project development since May 2022. With a robust background in pharmaceutical formulation and development, she has held managerial roles at a variety of companies in France. Ms Esseghir’s expertise includes establishing formulation laboratories, project piloting and creating strategic partnerships. She holds a master’s degree in Pharmaceutical Technology from Université Paris Cité (Paris, France) and a doctorate in Pharmacy from Faculté de Pharmacie de Monastir (Tunisia). Passionate about advancing pharmaceutical innovations, she uses her analytical skills and industry experience to improve patient outcomes.
Dr. Nikhil A. Khadabadi is a distinguished medical professional with extensive expertise in orthopaedics, medical devices, and healthcare innovation. As Chief Medical Officer at Eclevar Medtech, he oversees global clinical research initiatives, regulatory strategies, and post-market clinical follow-up (PMCF) activities, contributing significantly to advancing patient safety and medical device innovation. During his tenure at TÜV SÜD, he played a pivotal role as a Clinical Reviewer, evaluating high-risk Class IIa, IIb, and III devices under EU MDD and MDR regulations. His work encompassed critical assessments of prosthetic joint replacements, spinal implants, and dental devices, ensuring compliance with global standards and fostering innovation.
In addition to his contributions to Eclevar Medtech, Dr. Khadabadi leads the clinical team at Milo AI Healthcare, a pioneering platform that leverages artificial intelligence to revolutionize medical decision-making in clinical trials. Under his leadership, Milo AI Healthcare has developed cutting-edge solutions that integrate clinical insights with advanced AI technologies, transforming the healthcare landscape. His dual focus on clinical excellence and technological innovation exemplifies his commitment to improving patient outcomes and driving meaningful progress in the healthcare and medtech sectors.
Bogdan Sandica, a seasoned professional with over 10 years of experience in clinical research, specializing in early-phase studies. As a Senior Trial Optimization Manager at ARENSIA Exploratory Medicine, Bogdan collaborates closely with Sponsors, CROs, and multidisciplinary teams to ensure regulatory compliance and the delivery of high-quality data outcomes.
